
               
               
               
                  7 DRUG INTERACTIONS
               
               
                  
                     
                        Inhibitors of CYP2C8 (e.g., gemfibrozil) may increase rosiglitazone levels; inducers of CYP2C8 (e.g., rifampin) may decrease rosiglitazone levels. (7.1)
                     
                  
               
               
                  
                     
                     
                     
                        7.1 CYP2C8 Inhibitors and Inducers
                     
                        An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).]Â 
                        
                     
                     
                  
               
            
         